Financial statements Carboxygen
Balance sheet data of CARBOXYGEN
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 436 761,29 | 396 489,77 | 320 954,79 |
| A. Fixed assets | 327 508,08 | 192 712,75 | 121 658,71 |
| B. Current assets | 109 253,21 | 203 777,02 | 199 296,08 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
| Total liabilities | 436 761,29 | 396 489,77 | 320 954,79 |
| A. Equity | 210 154,22 | 216 339,24 | 189 552,35 |
| B. Liabilities and provisions for liabilities | 226 607,07 | 180 150,53 | 131 402,44 |
| I. Long-term liabilities | 150 771,08 | 106 267,02 | 61 586,07 |
| II. Short-term liabilities | 75 835,99 | 73 883,51 | 69 816,37 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.